Criteria |
Number (%) |
Progressing |
Slowly progressing |
20 (83,3) |
Quickly progressing |
3 (12,5) |
With no marked progression |
1 (4,2) |
Initial manifestation |
0 |
Extraarticular manifestations |
There are |
2 (8,3) (rheumatoid nodules in anamnesis) |
There are no |
22 (91,7) |
Immunologic characteristics |
RF positive |
24 (100,0) |
RF negative |
0 |
antiCCP positive |
18 (75,0) |
antiCCP negative |
6 (25,0) |
Shared Epitopes |
There are |
17 (70,8) |
There are no |
7 (29,2) |
Activity (DAS28-ESR) |
Minimal |
10 (41,7) |
Moderate |
14 (58,3) |
High |
0 |
Roentgenologic stage |
I |
0 |
II |
0 |
III |
18 (75,0) |
IV |
6 (25,0) |
Joint functional deficiency (HAQ) |
0 |
4 (16,7) |
I |
14 (58,3) |
II |
6 (25,0) |
III |
0 |
IV |
0 |